Navigation Links
Role of estrogen in colon cancer prevention, treatment studied at UH
Date:10/21/2013

HOUSTON, Oct. 21, 2013 As the second leading cause of cancer-related deaths in the U.S., colon cancer affects both men and women and is expected to cause more than 50,000 deaths this year. University of Houston (UH) professor Cecilia Williams has been awarded a $1.56 million grant from the National Cancer Institute (NCI) to investigate the mechanistic basis for novel colon cancer prevention and therapy.

While a truly preventive or targeted therapy against colon cancer does not yet exist, estrogen has been shown to reduce incidence of this disease. Williams, an assistant professor with the UH Center for Nuclear Receptors and Cell Signaling (CNRCS), plans to provide a detailed understanding of the role and potential of the nuclear receptor estrogen receptor beta (ERbeta) in colon cancer prevention and treatment.

A large body of work has suggested that signals conveyed by estrogen can prevent or delay colon cancer development, but little is understood of the underlying mechanisms. Williams' lab offers unique models and data that can clarify how estrogen influences colon cancer development. Through this five-year project, the lab will investigate the mechanistic basis for novel colon cancer prevention and therapy using ERbeta to validate biomarkers and develop future therapy and prevention strategies.

"Our preliminary studies, performed with the help of graduate students Karin Edvardsson, Trang Vu and Philip Jonsson, have yielded positive results, and we look forward to expanding upon our research with this this NCI grant," Williams said. "Our goal is to increase opportunities for improved colon cancer prevention and therapies."

This work also involves experts within related fields, including Jonna Frasor at the University of Illinois at Chicago, who studies estrogen and inflammation in the breast; Dr. Christopher Garrett at the University of Texas M.D. Anderson Cancer Center, a colon cancer clinician; Preethi Gunaratne, a bioinformatics researcher and professor in the UH College of Natural Sciences and Mathematics; and UH CNRCS Director Dr. Jan-ke Gustafsson, who discovered ERbeta in the mid-1990s.

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services. The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training.


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. BUSM researchers identify genetic markers for testosterone, estrogen level regulation
2. Genetic markers for testosterone and estrogen level regulation identified
3. Maturitas publishes clinical guide on low-dose vaginal estrogens for vaginal atrophy
4. Estrogen helps keep joint pain at bay after hysterectomy
5. Estrogen plus progestin use linked with increased breast cancer incidence and mortality
6. Estrogen Level in Pregnancy May Affect Breast Cancer Risk in Daughters
7. Estrogen fuels autoimmune liver damage
8. NuvaRing Lawsuits Move Forward, as Federal Judge Rules that Plaintiffs’ Experts May Testify on “Bursts” of Estrogen Allegedly Delivered by NuvaRing, Wright & Schulte LLC
9. Exercise-related changes in estrogen metabolism may lower breast cancer risk
10. Estrogen Levels Tied to Risk for Sudden Cardiac Death in Study
11. New Stool Test Might Aid in Early Detection of Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Role of estrogen in colon cancer prevention, treatment studied at UH
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology: